Ginsenoside C-K

人参皂苷C-K

Report date: 2025/06/11 13:56:50
NME

Base Information

Drug NameGinsenoside C-K
Drug Alias NamePanaxoside20(S)-人参皂苷C-K20(S)-人参皂苷CK20(S)-Ginsenoside C-K20-O-beta-D-Glucopyranosyl-20(S)-protopanaxadiol +[14] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionCaspase-3 activatorsNuclear factor NF-kappa-B complex inhibitorsGlucocorticoid receptor agonists
TargetsNuclear factor NF-kappa-B complexCaspase-3Glucocorticoid receptor
Therapy Area/IndicationsArthritis, RheumatoidMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth KoreaMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesRohtoZhejiang Hisun Pharmaceutical Co LtdState Pharmaceutical Administration of Shanghai Institute of Pharmaceutical Industry +[5] 
China Registration ClassN/A

Develop Information

Active CompaniesKBlueBio IncFudan UniversityZhejiang Hisun Pharmaceutical Co Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsArthritis, RheumatoidMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A